March 07, 2025

Scientists discover the function of a mysterious HIV component

Scientists discover the function of a mysterious HIV component

A research team including scientists from Heidelberg University Hospital has gained new insights into HIV-1.

Researchers from Martinsried, Heidelberg und Yale have discovered the mechanism behind an important step in the life cycle of HIV. Working together with teams at Heidelberg and Yale Universities, they found that the enigmatic “spacer peptide 2”, one of the virus components, plays a key role in converting immature HIV-1 particles into infectious particles. The results of the study were published in the journal Nature.

HIV-1 particles are released from infected cells in an immature, non-infectious form. The main building material for a virus particle is about 2000 copies of a long, rod-shaped protein called Gag. To become infectious, HIV has to undergo a maturation process. This involves the HIV-1 protease (a viral enzyme), that cuts up Gag into six smaller proteins including the capsid protein and the matrix protein. This causes a huge structural rearrangement of the virus components.

For many years, scientists have explored the structural changes of the virus capsid which encases the genome. In contrast, much less is known about the HIV-1 matrix – the outer protein shell directly beneath the lipid membrane that envelops the virus. Researchers led by John Briggs, Director and structural biologist at the Max Planck Institute of Biochemistry, have now worked out how the matrix protein rearranges during maturation into the infectious particle. They used the latest cryo-electron microscopes to image virus particles, and then used computational image analysis to derive very detailed 3D models of the viral proteins. Unexpectedly, they found that the rearrangement of matrix is triggered by “spacer peptide 2” which sticks to matrix and causes it to pack together in a different way. Spacer peptide 2 is another one of the six components formed by cutting up Gag, but its function was unknown until now. Binding of spacer peptide 2 to matrix protein allows the virus to fuse with target cells more quickly. The work was performed together with the research groups of Hans-Georg Kräusslich and Barbara Müller from the Department of Infectious Diseases, Virology, of Heidelberg University and partners from Yale University, USA.

To become infectious, HIV has to undergo a maturation process, which involves a rearrangement of the matrix-Proteins (red). In an immature virus particle, the matrix proteins form a lose lattice (upper left), while in a mature HIV, formation of a new, stable lattice triggered by binding of the protein spacer peptide 2 (blue, upper right). Illustration: Margot Riggi, MPI of Biochemistry

John Briggs explains: “In our lab, we obtained the first structural data about the matrix in 2021, but we didn’t know what caused it to rearrange when the virus matures. In this new study we produced much more detailed 3D views of the matrix layer, that was key to understanding what is going on.”

James Stacey and Dominik Hrebik the two first authors of the study explain their findings. James says: “The virus matrix has a pocket in its mature form. We knew that something binds there, but we thought it was a lipid from the membrane. Now we can see that it is spacer peptide 2. We wonder whether this pocket could be a target for drug molecules in the future” Dominik says: “Until now, the function of spacer peptide 2 was not known. Thanks to high-resolution cryo-electron microscopy, we have seen that this peptide, after its release, binds directly to the matrix proteins and links the proteins together in the mature virus.”

John Briggs summarizes: “HIV-1 is probably the most studied virus, but there are still important steps in its replication we don’t yet understand.”

Original Publication

James C. V. Stacey, Dominik Hrebík, Elizabeth Nand, Snehith Dyavari Shetty, Kun Qu, Marius Boicu, Maria Anders-Össwein, Pradeep D. Uchil, Robert A. Dick, Walther Mothes, Hans-Georg Kräusslich, Barbara Müller & John A. G. Briggs: The conserved HIV-1 spacer peptide 2 triggers matrix lattice maturation, Nature, February 2025

DOI: 10.1038/s41586-025-08624-9
https://www.nature.com/articles/s41586-025-08624-9

Our latest News

discover more
More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

How can effective treatments for neuropsychiatric disorders be developed without having to accept unwanted side effects? Researchers at the NMI have made an important contribution to this field. In their recent paper, “NMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry,” they demonstrate how specifically targeting subunits of the NMDA receptor opens […]

Connecting tissue physical changes to what developing cells become

Connecting tissue physical changes to what developing cells become

Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development Summary Embryonic development is one of the most dynamic biological processes in nature. Cells and tissues organise and reorganise themselves following incredibly precise patterns, while remaining flexible and robust. Scientists […]

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Joint press release from the medical faculties of Heidelberg and Mannheim The DFG is providing funding of around €5.8 million to support the continuation of Research Training Group 2727, ‘Checkpoints of Innate Immunity in Cancer and Tissue Damage (InCheck)’, led by the Faculty of Medicine in Mannheim. More information in German below: Wie funktionieren die […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp